title: PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP.
authors.affiliation: Haematology Department, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. benedicte.deau-fischer@cch.aphp.fr.|Faculté de Médecine Sorbonne Paris Cité, Université Paris Descartes, Paris, France. benedicte.deau-fischer@cch.aphp.fr.
authors.forename: Benedicte
authors.initials: B
authors.lastname: Deau
authors.affiliation: Department of Haematology, Hôpital Saint Louis, Paris, France.
authors.forename: Patricia
authors.initials: P
authors.lastname: Franchi
authors.affiliation: Department of Histopathology, Hôpital Saint Louis, Paris, France.
authors.forename: Josette
authors.initials: J
authors.lastname: Briere
authors.affiliation: Department of Nuclear Medicine, Hôpital Saint Louis, Paris, France.
authors.forename: Jessica
authors.initials: J
authors.lastname: Ohnona
authors.affiliation: Haematology Department, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.|Faculté de Médecine Sorbonne Paris Cité, Université Paris Descartes, Paris, France.
authors.forename: Jerome
authors.initials: J
authors.lastname: Tamburini
authors.affiliation: Department of Haematology, Hôpital Saint Louis, Paris, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Thieblemont
authors.affiliation: Department of Haematology, Hôpital Saint Louis, Paris, France.
authors.forename: Pauline
authors.initials: P
authors.lastname: Brice
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D001761:Bleomycin; D011344:Procarbazine; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
keywords: (BEACOPP) Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin; Oncovin; Prednisone; Procarbazine; lymphoma; positron emission tomography/computerized tomography scan